The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Shire Australia Pty Limited Regulatory activities for this sponsor. Listen Print Share Loading... Type Australian Public Assessment Report (AusPAR) (1) Australian Public Assessment Report (AusPAR) (1) Designation or determination (1) Designation or determination (1) Date 2019 (2) (-) 2019 (2) 2020 (1) 2020 (1) 2018 (3) 2018 (3) Search Filters applied:2019Clear all Sponsor content2 result(s) found, displaying 1 to 2 AusPAR: Icatibant (as acetate) 1 November 2019 Australian Public Assessment Report (AusPAR) Australian Public Assessment Report for Icatibant (as acetate) Notice for teduglutide (Shire Australia Pty Limited) 26 February 2019 Designation or determination Orphan drug
AusPAR: Icatibant (as acetate) 1 November 2019 Australian Public Assessment Report (AusPAR) Australian Public Assessment Report for Icatibant (as acetate)
Notice for teduglutide (Shire Australia Pty Limited) 26 February 2019 Designation or determination Orphan drug